Ardelyx Inc

ARDX

Healthcare|Biotechnology|USA

$5.28

-0.10 (-1.77%)

Tangible Book

$0.60

Upcoming Data Readouts (3)

Sep 2026

Est. completion

P3Irritable Bowel Syndrome With Constipation (IBS-C)

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

Dec 2026

Est. completion

P2Synucleinopathy

Tenapanor in Synucleinopathy-Related Constipation

Feb 2027

Est. completion

P3Chronic Idiopathic Constipation (CIC)

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Trials past primary completion date but still active — data readout may be imminent.

Jul 2026

4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs